Wikidata

(Q64150304)

English

Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

start time
10 February 2016
0 references
end time
December 2019
0 references
number of participants
20
0 references
minimum age
20 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64150304&oldid=2235453013"